Market News
Latest financial news and analysis from global markets
MSFT
The Biggest Roadblock Between the S&P and Another Record? Big Tech.
Large technology stocks were a major roadblock for the S&P 500 on Thursday. Of the seven so-called Magnificent Seven stocks, only three were trading higher: Microsoft, up 1.6%, Meta Platforms, up 0.3%, and Amazon.com, up 0.1%.
AMZN
The Biggest Roadblock Between the S&P and Another Record? Big Tech.
Large technology stocks were a major roadblock for the S&P 500 on Thursday. Of the seven so-called Magnificent Seven stocks, only three were trading higher: Microsoft, up 1.6%, Meta Platforms, up 0.3%, and Amazon.com, up 0.1%.
AAPL
The Biggest Roadblock Between the S&P and Another Record? Big Tech.
Large technology stocks were a major roadblock for the S&P 500 on Thursday. Of the seven so-called Magnificent Seven stocks, only three were trading higher: Microsoft, up 1.6%, Meta Platforms, up 0.3%, and Amazon.com, up 0.1%.
TSLA
The Biggest Roadblock Between the S&P and Another Record? Big Tech.
Large technology stocks were a major roadblock for the S&P 500 on Thursday. Of the seven so-called Magnificent Seven stocks, only three were trading higher: Microsoft, up 1.6%, Meta Platforms, up 0.3%, and Amazon.com, up 0.1%.
GOOGL
The Biggest Roadblock Between the S&P and Another Record? Big Tech.
Large technology stocks were a major roadblock for the S&P 500 on Thursday. Of the seven so-called Magnificent Seven stocks, only three were trading higher: Microsoft, up 1.6%, Meta Platforms, up 0.3%, and Amazon.com, up 0.1%.
XAU/USD
Fortitude Gold (FTCO) Bounced Back From Its Worst Year, But One Risk Could Unwind the Gains
Gold crossed $2,000 in January 2026 and Goldman Sachs lifted its December 2026 price target to $2,500, driven by central bank buying that now averages roughly 1,037 tonnes annually versus a pre-2022 average of 17. For a small Nevada gold producer sitting on permitted, in-ground gold deposits, that price environment is the primary driver of ... Fortitude Gold (FTCO) Bounced Back From Its Worst Year, But One Risk Could Unwind the Gains
AAPL
3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
Option-income ETFs have carved out a distinct niche in the fund market by turning volatility into regular cash distributions. Three popular funds illustrate how wide the range of approaches and tradeoffs can be: a mega-cap tech covered call strategy with institutional scale, a single-stock crypto bet that pays out weekly, and a multi-name high-volatility portfolio ... 3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
NVDA
3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
Option-income ETFs have carved out a distinct niche in the fund market by turning volatility into regular cash distributions. Three popular funds illustrate how wide the range of approaches and tradeoffs can be: a mega-cap tech covered call strategy with institutional scale, a single-stock crypto bet that pays out weekly, and a multi-name high-volatility portfolio ... 3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
GOOGL
3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
Option-income ETFs have carved out a distinct niche in the fund market by turning volatility into regular cash distributions. Three popular funds illustrate how wide the range of approaches and tradeoffs can be: a mega-cap tech covered call strategy with institutional scale, a single-stock crypto bet that pays out weekly, and a multi-name high-volatility portfolio ... 3 Option-Income ETFs to Buy Now for Monthly Cash Flow in 2026
ABT
Equity Markets Rise Intraday as Trump Announces Israel-Lebanon Ceasefire
US benchmark equity indexes were higher intraday as President Donald Trump said Lebanon and Israel a
NVDA
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
There are other factors to consider before investing in this -- or any other -- healthcare company.
INTC
Should You Forget CVS Health and Invest in a Purer Healthcare Play?
There are other factors to consider before investing in this -- or any other -- healthcare company.